Skip to main content
Premium Trial:

Request an Annual Quote

Protagen, Qiagen Collaborate to Advance Development of Protein-based CDx for Autoimmune Diseases

NEW YORK (GenomeWeb) – Diagnostics firm Protagen announced a long-term collaboration agreement with Qiagen to provide pharmaceutical partners access to technology that would advance the development of protein-based companion tests for autoimmune disorders.

The terms of the agreement give Qiagen access to Protagen's proprietary SeroTag, an automated multiplex technology that can facilitate the discovery and validation of protein-based biomarker panels. SeroTag can measure autoantibody levels for thousands of antigens from a patient's single serum sample.

According to Qiagen, the technology can support Phase I to Phase IV drug development programs for autoimmune illnesses, as well as enable the development of companion tests for better disease diagnosis, patient stratification in clinical trials, and improved treatment strategies.

"The synergistic combination of the unique expertise of Qiagen and Protagen in the development and commercialization of companion diagnostics will offer a complete solution for pharmaceutical and biotech companies targeting the development of new therapeutic compounds, diagnostic, or companion diagnostic tests in the area of autoimmune disorders," the companies said in a statement.

Protagen and Qiagen did not disclose the financial details of their deal.

"Following cancer, autoimmune disorders are currently the second largest therapeutic area for companion diagnostics in drug development with a significant unmet medical need," Rainer Metzger, Qiagen's VP of business development pharma, noted in a statement.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.